PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity

Katie M. Parkins, Balaji Krishnamachary, Desmond Jacob, Samata M. Kakkad, Meiyappan Solaiyappan, Akhilesh Mishra, Yelena Mironchik, Marie France Penet, Michael T. McMahon, Philipp Knopf, Bernd J. Pichler, Sridhar Nimmagadd, Zaver M. Bhujwalla

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To examine the association between hypoxia and programmed cell death ligand 1 (PD-L1) expression using bioluminescence imaging (BLI) and PET/MRI in a syngeneic mouse model of triple-negative breast cancer (TNBC). Materials and Methods: PET/MRI and optical imaging were used to determine the role of hypoxia in altering PD-L1 expression using a syngeneic TNBC model engineered to express luciferase under hypoxia. Results: Imaging showed a close spatial association between areas of hypoxia and increased PD-L1 expression in the syngeneic murine (4T1) tumor model. Mouse and human TNBC cells exposed to hypoxia exhibited a significant increase in PD-L1 expression, consis-tent with the in vivo imaging data. The role of hypoxia in increasing PD-L1 expression was further confirmed by using The Cancer Genome Atlas analyses of different human TNBCs. Conclusion: These results have identified the potential role of hypoxia in contributing to PD-L1 heterogeneity in tumors by increasing cancer cell PD-L1 expression.

Original languageEnglish (US)
Article numbere220138
JournalRadiology: Imaging Cancer
Volume5
Issue number4
DOIs
StatePublished - Jul 2023

Keywords

  • Biolu-minescence Imaging
  • Hypoxia
  • PD-L1
  • PET/MRI
  • Triple-Negative Breast Cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Oncology

Fingerprint

Dive into the research topics of 'PET/MRI and Bioluminescent Imaging Identify Hypoxia as a Cause of Programmed Cell Death Ligand 1 Image Heterogeneity'. Together they form a unique fingerprint.

Cite this